PPBT (Purple Biotech Ltd. American Depositary Shares) Stock Analysis - AI Report

Purple Biotech Ltd. American Depositary Shares (PPBT) is a publicly traded Healthcare sector company. As of May 21, 2026, PPBT trades at $2.75 with a market cap of $3.51M and a P/E ratio of 0.00. PPBT moved -11.11% today. Year to date, PPBT is -57.03%; over the trailing twelve months it is -87.63%. Its 52-week range spans $2.71 to $139.50. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces PPBT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on PPBT?

Rallies AI research for PPBT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

PPBT Key Metrics

Key financial metrics for PPBT
MetricValue
Price$2.75
Market Cap$3.51M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$139.50
52-Week Low$2.71
Volume11.76K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PPBT News

PPBT Analyst Consensus

1 analysts cover PPBT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.

Common questions about PPBT

What is the AI research view on PPBT?
Rallies AI research for PPBT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for PPBT?
Rallies AI research for PPBT combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is PPBT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PPBT. It does not provide personalized investment advice.
PPBT

PPBT